VRDN Reports $0 Revenue, $0 EPS, +94% YoY Growth, Launches Elegrobart Autoinjector for Chronic TED, BLA 2027, +50% Proptosis Response
Viridian Therapeutics, Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $16.96
-11% in 3d after detection
Post-detection moves
1h
—
1d
-6.5%
3d
-11%
7d
-7.0%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS